CJC1295-IPA 5/5 is a combination peptide product containing CJC1295 and IPA (Ipamorelin), with 5mg of each peptide in a single vial. It is formulated for laboratory research involving peptide signaling, receptor interactions, and growth hormone-related pathways.
CJC1295 is a synthetic peptide studied in relation to growth hormone-releasing hormone (GHRH) pathways, while IPA (Ipamorelin) is studied for its interaction with growth hormone secretagogue receptor pathways. The combination provides researchers with two distinct peptide compounds for controlled laboratory investigations.
The product is supplied as a lyophilized powder and is intended for qualified research environments where appropriate laboratory handling and safety procedures are followed.
Product Information
- Product Name: CJC1295-IPA 5/5
- Amount: 5mg / 5mg
- Composition: CJC1295 5mg + IPA 5mg
- Product Type: Synthetic peptide combination
- Format: Lyophilized powder
- Research Category: Peptide research
Research Focus
CJC1295-IPA is studied in laboratory research involving:
- Peptide-receptor interactions
- GHRH-related signaling pathways
- Growth hormone-related mechanisms
- Cellular signaling
- Endocrine research
- Peptide structure and activity
Research Use Disclaimer
This product is intended for research use only. It is not intended for human or veterinary use, consumption, diagnosis, treatment, cure, or prevention of any disease or medical condition. It should be handled only by qualified personnel in an appropriate laboratory environment and in accordance with applicable safety procedures and regulations.
Reviews
There are no reviews yet.